MedPath

Polyethylene glycol

Generic Name
Polyethylene glycol
Brand Names
Bi-peglyte, Clearlax, Colyte, Gavilax, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Gentlelax, Gialax, Glycolax, Golytely, Healthylax, Miralax, Moviprep, Nulytely, Peglyte, Pegylax, Plenvu, Purelax, Suflave
Drug Type
Small Molecule
CAS Number
25322-68-3
Unique Ingredient Identifier
3WJQ0SDW1A
Background

Polyethylene glycol (PEG) is a synthetic polymer produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an ether linkage. PEGs are water-soluble polymers that can form hydrogen bonds in a ratio of 100 water molecules per one PEG molecule. Molecular weights of PEGs vary by time of the polymerization process and the molecular weight represents the weighted average of the individual PEG molecules. PEGs differ in their physical and chemical properties depending on their molecular weight: PEGs are liquids when molecular weights are <1000 and the molecule turns to waxy solids with increasing molecular weights. The most common preparations of PEGs include PEG 3350 and PEG 400. PEGs have various applications in many fields, ranging from medical to industrial areas. PEGs have a long history of gastroenterology: PEG 3350 is a common over-the-counter osmotic laxative used to relieve occasional constipation. PEG 3350 is also used for cleansing of the colon in preparation for colonoscopy in adults.

The rationale of using PEG in gastroenterology is due to the physical properties of the compound: its potent water-binding capacity, negligible intestinal absorption with increasing molecular mass, lack of significant toxicity, and limited intestinal enzymatic degradation or bacterial metabolism all make PEG a useful therapeutic agent for the treatment of occasional constipation and bowel cleansing for preparation in colonoscopy.

Indication

Polyethylene glycol is indicated for use as an over-the-counter osmotic laxative to relieve occasional constipation. When used in combination with sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride, it is used for cleansing of the colon in preparation for colonoscopy in adults.

Associated Conditions
Chronic Constipation, Constipation, Dry Eye Syndrome (DES), Dry Eyes, Occasional Constipation
Associated Therapies
Bowel preparation therapy, Eye lubrication

Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen

Phase 4
Recruiting
Conditions
Constipation
Interventions
Drug: PEG-3350 with electrolytes
First Posted Date
2023-04-20
Last Posted Date
2024-08-05
Lead Sponsor
Indiana University
Target Recruit Count
50
Registration Number
NCT05821309
Locations
🇺🇸

Riley Hospital for Children, Indianapolis, Indiana, United States

🇺🇸

IU North Hospital, Carmel, Indiana, United States

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Phase 1
Recruiting
Conditions
Sarcoma,Soft Tissue
Soft Tissue Sarcoma
Sts
Interventions
First Posted Date
2023-04-14
Last Posted Date
2025-05-16
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
35
Registration Number
NCT05813327
Locations
🇺🇸

University of Colorado Hospital, Aurora, Colorado, United States

🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Preop Laxatives in Robotic Urologic Surgery

Phase 4
Recruiting
Conditions
Prostate Cancer
Kidney Cancer
Constipation
Interventions
First Posted Date
2023-04-10
Last Posted Date
2023-12-26
Lead Sponsor
Chad R. Tracy
Target Recruit Count
240
Registration Number
NCT05805436
Locations
🇺🇸

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure

Phase 3
Completed
Conditions
Colon Polyp
Colon Cancer
Inflammatory Bowel Diseases
Gastrointestinal Bleed
Interventions
Drug: polyethylene glycol + ascorbic acid
Drug: magnesiumoxid + sodium picosulfate
First Posted Date
2023-02-13
Last Posted Date
2024-02-28
Lead Sponsor
Region Skane
Target Recruit Count
147
Registration Number
NCT05726097
Locations
🇸🇪

Skåne University Hospital, Malmö, Sweden

Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults

Not Applicable
Completed
Conditions
Polyethylene Glycol
Lactulose
Bowel Preparation
Colonoscopy
Bisacodyl
Interventions
First Posted Date
2023-02-13
Last Posted Date
2023-12-27
Lead Sponsor
Hospital de Clínicas Dr. Manuel Quintela
Target Recruit Count
150
Registration Number
NCT05726344
Locations
🇺🇾

Hospital de Clinicas, Montevideo, Uruguay

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects with Leiomyosarcoma (ARGSARC)

Phase 3
Recruiting
Conditions
Soft Tissue Sarcoma
Interventions
Other: Placebo
First Posted Date
2023-02-03
Last Posted Date
2025-03-12
Lead Sponsor
Polaris Group
Target Recruit Count
300
Registration Number
NCT05712694
Locations
🇺🇸

Mayo Clinic Arizona, Phoenix, Arizona, United States

🇺🇸

USC Norris comprehensive cancer center, Los Angeles, California, United States

🇺🇸

UCSF, San Francisco, California, United States

and more 26 locations

Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation in Low-risk Patients

Not Applicable
Completed
Conditions
Colonic Neoplasms
Interventions
First Posted Date
2022-12-13
Last Posted Date
2022-12-13
Lead Sponsor
Zhang Xiaofeng,MD
Target Recruit Count
255
Registration Number
NCT05648318
Locations
🇨🇳

Hangzhou first people's Hospital, Hangzhou, Zhejiang, China

Polyethylene Glycol Safety in Children

Active, not recruiting
Conditions
Children, Only
Polyethylene Glycols
Interventions
First Posted Date
2022-06-21
Last Posted Date
2024-12-16
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
158
Registration Number
NCT05424757
Locations
🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Application of Linaclotide Capsule in Bowel Preparation for Patients at High Risk of Inadequate Bowel Preparation

Not Applicable
Completed
Conditions
Colonoscopy
Interventions
Drug: 3 L PEG + placebo
First Posted Date
2022-05-18
Last Posted Date
2024-05-23
Lead Sponsor
Zhiguo Liu
Target Recruit Count
720
Registration Number
NCT05379491
Locations
🇨🇳

Ningxia Hui Autonomous Region People's Hospital, Yinchuan, Ningxia, China

🇨🇳

Xi'an Jiaotong University Second Affiliated Hospital, Xi'an, Shaanxi, China

🇨🇳

Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China

and more 5 locations

High-Volume Vs Low-Volume Preparation in Emergency Department

Not Applicable
Completed
Conditions
GastroIntestinal Bleeding
Interventions
First Posted Date
2022-05-05
Last Posted Date
2023-04-04
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
228
Registration Number
NCT05362227
Locations
🇮🇹

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath